BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.

Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.

Diabetes Videos

see all videos

Support clinical trials, provide research fellowships, purchase specialized equipment, and fund the creation of the “BGU Mouse.”

Donate to
Diabetes

Diabetes News

see all news
“Super Enzyme” Improves Glucose Level Testing

September 28, 2017

Tags: Medical Research, Natural Sciences

BGU researchers engineer a new method that measures blood-sugar levels faster and more accurately.

Reversing Type 1 Diabetes

April 19, 2017

Tags: Medical Research

Using the alpha-1 protein, Prof. Eli Lewis has eliminated some patients’ need for insulin injections.

Wine Has Demonstrable Benefits for Type 2 Diabetes

June 1, 2016

Tags: Medical Research

A two-year BGU study shows moderate wine consumption can raise good cholesterol while lowering the bad.